Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : OMTX705
Therapeutic Area : Oncology
Study Phase : IND Enabling
Sponsor : Oncomatryx
Deal Size : Undisclosed
Deal Type : Collaboration
TFS Expands Partnership with Oncomatryx for OMTX705 Pancreatic Cancer Trial
Details : The collaboration aims to advance the clinical development of OMTX705 in patients with advanced or metastatic pancreatic adenocarcinoma.
Product Name : OMTX705
Product Type : Antibody-drug Conjugate
Upfront Cash : Undisclosed
May 06, 2025
Lead Product(s) : OMTX705
Therapeutic Area : Oncology
Highest Development Status : IND Enabling
Sponsor : Oncomatryx
Deal Size : Undisclosed
Deal Type : Collaboration